OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Casirivimab-imdevimab neutralizing SARS-CoV-2: post-infusion clinical events and their risk factors
Junichi Yoshida, Kenichiro Shiraishi, Tetsuro Tamura, et al.
Journal of Pharmaceutical Health Care and Sciences (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 8
Junichi Yoshida, Kenichiro Shiraishi, Tetsuro Tamura, et al.
Journal of Pharmaceutical Health Care and Sciences (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 8
Showing 8 citing articles:
Effects of Casirivimab/Imdevimab Monoclonal Antibody Treatment among Vaccinated Patients Infected by SARS-CoV-2 Delta Variant
Gaetano Cicchitto, Lorena Cardillo, Claudio de Martinis, et al.
Viruses (2022) Vol. 14, Iss. 3, pp. 650-650
Open Access | Times Cited: 16
Gaetano Cicchitto, Lorena Cardillo, Claudio de Martinis, et al.
Viruses (2022) Vol. 14, Iss. 3, pp. 650-650
Open Access | Times Cited: 16
SARS-CoV-2: An Overview of the Genetic Profile and Vaccine Effectiveness of the Five Variants of Concern
Raluca Dumache, Alexandra Enache, Ioana Macașoi, et al.
Pathogens (2022) Vol. 11, Iss. 5, pp. 516-516
Open Access | Times Cited: 14
Raluca Dumache, Alexandra Enache, Ioana Macașoi, et al.
Pathogens (2022) Vol. 11, Iss. 5, pp. 516-516
Open Access | Times Cited: 14
Effect of Casirivimab/Imdevimab Treatment on Serum Type I Interferon Levels in SARS-CoV-2 Infection
Kentaro Nagaoka, Hitoshi Kawasuji, Yusuke Takegoshi, et al.
Viruses (2022) Vol. 14, Iss. 7, pp. 1399-1399
Open Access | Times Cited: 4
Kentaro Nagaoka, Hitoshi Kawasuji, Yusuke Takegoshi, et al.
Viruses (2022) Vol. 14, Iss. 7, pp. 1399-1399
Open Access | Times Cited: 4
Sotrovimab use in Japanese inpatients with COVID-19: post-infusion adverse events
Junichi Yoshida, Kenichiro Shiraishi, Masao Tanaka
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Junichi Yoshida, Kenichiro Shiraishi, Masao Tanaka
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Effectiveness of Sotrovimab in the Omicron Storm Time: A Case Series
Gaetano Cicchitto, Lorena Cardillo, Davide Sequino, et al.
Viruses (2022) Vol. 15, Iss. 1, pp. 102-102
Open Access | Times Cited: 3
Gaetano Cicchitto, Lorena Cardillo, Davide Sequino, et al.
Viruses (2022) Vol. 15, Iss. 1, pp. 102-102
Open Access | Times Cited: 3
Pharmacotherapeutic Treatment Strategies COVID-19: Lessons Learned and Perspectives
Abdurashid Khamidovich Ashirmetov
Exploratory Research and Hypothesis in Medicine (2022) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 2
Abdurashid Khamidovich Ashirmetov
Exploratory Research and Hypothesis in Medicine (2022) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 2
Sotrovimab neutralizing SARS-CoV-2: Risk factors for post-infusion clinical events
Junichi Yoshida, Kenichiro Shiraishi, Hirotaka Noda, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 1
Junichi Yoshida, Kenichiro Shiraishi, Hirotaka Noda, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 1
Pandemic stewardship on antimicrobials: A historical control study before and after COVID-19 care in a teaching hospital
Junichi Yoshida, Kenichiro Shiraishi, Tetsuya Kikuchi, et al.
Research Square (Research Square) (2022)
Open Access
Junichi Yoshida, Kenichiro Shiraishi, Tetsuya Kikuchi, et al.
Research Square (Research Square) (2022)
Open Access
